Ifex/Mesnex Alternatives Compared
Ifex/Mesnex | Cisplatin | Etoposide |
|
---|
Ifex/Mesnex (ifosfamide / mesna) | Cisplatin | Etoposide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Testicular Cancer. Ifex/Mesnex may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bladder Cancer, Anal Cancer, Bone Marrow Transplantation, Blood Cell Transplantation, Brain Tumor, Cervical Cancer, Nasopharyngeal Carcinoma, Neuroblastoma, Non-Small Cell Lung Cancer... View more |
Prescription only
Prescribed for Small Cell Lung Cancer, Hodgkin's Lymphoma, Ovarian Cancer, Testicular Cancer, Cancer, Multiple Myeloma. etoposide may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Cisplatin | More about Etoposide | |||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Cisplatin has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Ifex/Mesnex side effects in more detail. |
See also: cisplatin side effects in more detail. |
See also: etoposide side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all cisplatin prices |
View all etoposide prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
Etopophos, Toposar | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
15 hours |
73 hours |
11 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 565 drugs are known to interact with Ifex/Mesnex:
|
A total of 438 drugs are known to interact with cisplatin:
|
A total of 437 drugs are known to interact with etoposide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
December 19, 1978 |
December 30, 1986 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.